Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02718157 · ClinicalTrials.gov registry record · NA
Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains
A NA study, sponsored by Meridian Bioscience.
- Completed
- Registry status
- NA
- Development phase
- 771
- Enrollment target
NCT02718157 is a NA study that has completed, run by Meridian Bioscience. The registered enrollment target is 771 participants.
The verdict
NCT02718157, a NA study, has completed, sponsored by Meridian Bioscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 771 participants
- Enrollment target
Study Summary
The primary purpose of this clinical investigation is to verify the performance of the GenePOC GBS Assay on the GenePOC Instrument. This will be achieved by comparing the Assay to the a Culture, a conventional method for detection of Streptococcus agalactiae in vaginal/rectal swab specimens from antepartum women.
Interventions
- DEVICE Comparison between GenePOC PCR and Reference Method
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 771 participants |
| Start Date | 2016-08-10 |
| Est. Completion | 2017-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02718157
The ClinicalTrials.gov registry entry for NCT02718157 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 771 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Meridian Bioscience, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Comparison between GenePOC PCR and Reference Method is the first listed.
NCT02718157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02718157 about?
NCT02718157 is a clinical study titled "Validation of the GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains". The primary purpose of this clinical investigation is to verify the performance of the GenePOC GBS Assay on the GenePOC Instrument. This will be achieved by comparing the Assay to the a Culture, a conventional method for detection of Streptococcus agalactiae in vaginal/rectal swab specimens from ant...
What is the current status of trial NCT02718157?
This trial is currently completed. It is a NA study. The enrollment target is 771 participants. The study started on 2016-08-10. Estimated completion is 2017-02-07.
What interventions are being tested in trial NCT02718157?
The interventions under investigation include: Comparison between GenePOC PCR and Reference Method (DEVICE).
Who is sponsoring clinical trial NCT02718157?
This trial is sponsored by Meridian Bioscience, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.